Peak Pharmaceutical Commends Advanced of the Year


Release time:

2022-02-10

On January 27, the summary and commendation meeting held by Jianfeng Pharmaceutical Co., Ltd. presented awards to advanced collectives and outstanding individuals, summarized the work of the previous year, deployed the work of the new year, and signed the target responsibility system for the next year with the heads of subordinate enterprises.

    1Month27Day, Peak Pharmaceuticals.The summary and commendation meeting held presented awards to advanced collectives and outstanding individuals, summarized the work of the previous year, deployed the work of the new year, and signed the target responsibility system for the next year with the heads of subordinate enterprises.

    In the work report, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, summarized the pharmaceutical company's previous year's adjustment of internal management structure, institutional settings, sales area optimization, integration of financial accounting systems, optimization of processes, and strengthening of quality control. Achievements in project construction, information construction, etc. In the face of frequent national pharmaceutical industry policies, drug collection speed expansion, continuous promotion of the status quo, pharmaceutical companies next year will pay more attention to medical insurance, basic drugs, key monitoring and other catalogs, focus on doing a good job in the market access of drugs around the work, innovative marketing system, tap product advantages, enhance market expansion capacity.

    Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, and the management team of the pharmaceutical company presented awards to advanced collectives and outstanding individuals. Wu Weisheng, He Songqin, Wang Liqin, and Chen Yumiao respectively represented the group's outstanding management workers, advanced collectives, and outstanding scientific and technological workers. And outstanding members delivered acceptance speeches.

 

    In the concluding speech of the meeting, Jiang Xiaomeng commented on the work of the pharmaceutical company in the previous year and on the peak pharmaceutical sector.2022The direction of the work of the year to provide guidance. He emphasized that the group company has always placed high hopes on the future development of pharmaceutical companies. Pharmaceutical companies must break through their inherent thinking, seize profit points, and improve weak points. Find the right track, develop ophthalmic drugs, strengthen the development of improved drugs, power medical intermediates. Compaction responsibility, serious reflection review, find ways to improve the speed of new drug development, clear idle capacity. The combination of sales guarantee and increase, open the sales market, broaden the sales channels, guarantee the quantity of basic products, seize the market opportunity to create benefits, and strive to greatly increase the sales volume. Improve quality and reduce costs in production, starting from the procurement of raw materials, the quality of production workers and the improvement of production processes to reduce production costs. Work together in many ways to get out of the bottleneck and reach the annual goal for the new year.